
Low treatmentadherence
Poor adherence to treatments has been associated with an increase number of patients with multi-chronic diseases. These parallels have contributed to compromised patient outcomes and an increase in healthcare costs. Improving treatment adherence is becoming a key priority for healthcare actors to balance the cost of our healthcare systems.
Global economic pressure on pharma sector
Pharma companies have to cope with governments pressure to contain healthcare expenditure. In Europe, growth rates are declining and valued at 1-4% over the next 5 years in comparison to previous years which was 5%. In this context, efficiency, profitability, and innovative approaches are necessary to safeguard sustainable growth in the industry.


Generic drugscompetition
90% of the current Top 20 world drugs will compete against a generic or biosimilar drug by 2023. The loss of revenues is estimated at nearly $120 billion in developed country markets (2019-2023). Shortening the period of active promotion of Rx products requires offensive and efficient commercial strategies.
Beyond the pillapproach
Governments, patients and HCP’s all expect pharma companies to bring added value support for health products, which implies offering a full range of services throughout the product life cycle. Added value services such as Patients Support Programs are the new excepted model: scientific projects with MSLs, web conferences with KOLs, mobile apps for healthcare practitioners and patients, drug delivery, patient support programs etc.


Low treatment adherence
Poor adherence to treatments has been associated with an increase number of patients with multi-chronic diseases. These parallels have contributed to compromised patient outcomes and an increase in healthcare costs. Improving treatment adherence is becoming a key priority for healthcare actors to balance the cost of our healthcare systems.

Global economic pressureon pharma sector
Pharma companies have to cope with governments pressure to contain healthcare expenditure. In Europe, growth rates are declining and valued at 1-4% over the next 5 years in comparison to previous years which was 5%. In this context, efficiency, profitability, and innovative approaches are necessary to safeguard sustainable growth in the industry.

Generic drugs competition
90% of the current Top 20 world drugs will compete against a generic or biosimilar drug by 2023. The loss of revenues is estimated at nearly $120 billion in developed country markets (2019-2023). Shortening the period of active promotion of Rx products requires offensive and efficient commercial strategies.

Beyond the pill approach
Governments, patients and HCP’s all expect pharma companies to bring added value support for health products, which implies offering a full range of services throughout the product life cycle. Added value services such as Patients Support Programs are the new excepted model: scientific projects with MSLs, web conferences with KOLs, mobile apps for healthcare practitioners and patients, drug delivery, patient support programs etc.
Why we are the perfect match
Our Efficiency
Relying on Consultants, Pharmacists & Doctors, Nurses & Certified Medical Reps, we have a long-standing experience in supporting our customers in their evolving markets.
Our Quality
More than 100 pharma companies, hospitals, insurance companies trust our ability to help them to face their new challenges: increasing the digital share in promotion, facing competition from generic players and developing innovative services.
Our Innovation
Innovation is part of our DNA. Pioneer in direct sales, hybrid promotion and patients support programs, we aim at designing new healthcare models. Our track-record for innovation is enhanced with 20 years of valuable behavioural data collected from French pharmicists and doctors. This has enabled us to create fully customizable proprietary tools and a hybrid approach for their preferences.
Why we are the perfect match
Relying on Consultants, Pharmacists & Doctors, Nurses & Certified Medical Reps, we have a long-standing experience in supporting our customers in their evolving markets.
More than 100 pharma companies, hospitals, insurance companies trust our ability to help them to face their new challenges: increasing the digital share in promotion, facing competition from generic players and developing innovative services.
Innovation is part of our DNA. Pioneer in direct sales, hybrid promotion and patients support programs, we aim at designing new healthcare models. Our track-record for innovation is enhanced with 20 years of valuable behavioural data collected from French pharmicists and doctors. This has enabled us to create fully customizable proprietary tools and a hybrid approach for their preferences.


Let's talkabout you!
Client stories
Our Vision & Culture
Our Vision: To be the greatest customer engagement company in the world rich in diversity and talent - powered by…
Our promise
Our Promise: To challenge conventions. To deliver outcomes unimagined. By creating experiences that go beyond wow
Client stories
Our Vision & Culture
Our Vision: To be the greatest customer engagement company in the world rich in diversity and talent - powered by…
Our promise
Our Promise: To challenge conventions. To deliver outcomes unimagined. By creating experiences that go beyond wow
Latest news about Healthcare
United Kingdom,News,Articles,Healthcare,India,South Africa
Driving Greater Adoption of HealthTech Innovation Within Healthcare systems like the NHS and Ensuring a Patient Centric Experience
The panellists at the 2023 LSX World Congress exchanged ideas on how to create patient-centric solutions and the best…
News,Articles,Healthcare,India,South Africa,United Kingdom
Turning the tide: saving the NHS with augmented human capability
Emma Bouché, Head of Healthcare, Webhelp UK, explains how the NHS could reduce waste and improve capacity through…
Articles,Digital services,Fashion & Luxury,Financial Services,Healthcare,High Tech & Media,Telecom,Travel & Leisure
Outsourcing Content Moderation
This guide explains the pros and cons of both in-housing and outsourcing content moderation, as well how to find the…
Whitepapers,Retail & E-Commerce,Sales,Enterprise services,Fashion & Luxury,Financial Services,Healthcare,Telecom,Travel & Leisure
B2B’s third way eBook: Overcoming the limitations of third-party and owned data in B2B sales
Flawed data is slowing your business to business sales success. Download the eBook to learn about a new type of…
Retail & E-Commerce,Sales,Fashion & Luxury,Financial Services,Healthcare,Utilities & Public Services,Telecom,Travel & Leisure
Guide to the B2B Sales Funnel
Learn all about the B2B Sales funnel and see how to build an effective, customer-centric B2B funnel to suit modern…
Utilities & Public Services,Telecom,Travel & Leisure,Retail & E-Commerce,Sales,Fashion & Luxury,Financial Services,Healthcare
Build a B2B Sales Pipeline
Explore best practices for building a high–performing B2B sales pipeline & learn how it differs from a B2B sales…
UK Healthcare innovation continues to accelerate in 2022
Emma Bouché, Head of Healthcare, looks at how the seismic impact of COVID-19 has accelerated a culture of innovation…
Latest news about Healthcare
United Kingdom,News,Articles,Healthcare,India,South Africa
Driving Greater Adoption of HealthTech Innovation Within Healthcare systems like the NHS and Ensuring a Patient Centric Experience
The panellists at the 2023 LSX World Congress exchanged ideas on how to create patient-centric solutions and the best…
News,Articles,Healthcare,India,South Africa,United Kingdom
Turning the tide: saving the NHS with augmented human capability
Emma Bouché, Head of Healthcare, Webhelp UK, explains how the NHS could reduce waste and improve capacity through…
Articles,Digital services,Fashion & Luxury,Financial Services,Healthcare,High Tech & Media,Telecom,Travel & Leisure
Outsourcing Content Moderation
This guide explains the pros and cons of both in-housing and outsourcing content moderation, as well how to find the…
Whitepapers,Retail & E-Commerce,Sales,Enterprise services,Fashion & Luxury,Financial Services,Healthcare,Telecom,Travel & Leisure
B2B’s third way eBook: Overcoming the limitations of third-party and owned data in B2B sales
Flawed data is slowing your business to business sales success. Download the eBook to learn about a new type of…
Retail & E-Commerce,Sales,Fashion & Luxury,Financial Services,Healthcare,Utilities & Public Services,Telecom,Travel & Leisure
Guide to the B2B Sales Funnel
Learn all about the B2B Sales funnel and see how to build an effective, customer-centric B2B funnel to suit modern…